Glaxosmithkline [Merged] Financials
NSE: GSKCONS | BSE: 500676
₹10,732.60
₹496.30
(4.85%)
As on 15-Apr-2020IST
Market cap
₹45,225 Cr
Revenue (TTM)
₹4,984 Cr
P/E Ratio
39.1
P/B Ratio
10.2
Div. Yield
1 %
Income Statement (₹ Cr) |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
4,984.33
|
4,782.01
|
4,316.52
|
3,991.28
|
4,136.27
|
4,307.59
|
|
|
|
|
|
|
Total Income
|
5,427.97
|
5,214.61
|
4,573.92
|
4,230.34
|
4,413.78
|
4,529.47
|
|
|
|
|
|
|
Total Expenditure
|
3,717.56
|
3,641.04
|
3,433.16
|
3,152.97
|
3,298.11
|
3,577.50
|
|
|
|
|
|
|
EBITDA
|
1,266.77
|
1,140.97
|
883.36
|
838.31
|
838.16
|
730.08
|
|
|
|
|
|
|
Depreciation
|
74.04
|
60.50
|
64.37
|
64.18
|
57.44
|
62.09
|
|
|
|
|
|
|
EBIT
|
1,192.73
|
1,080.46
|
818.98
|
774.13
|
780.72
|
668.00
|
|
|
|
|
|
|
Interest
|
5.17
|
0.78
|
2.03
|
2.78
|
2.28
|
0.74
|
|
|
|
|
|
|
Other Income
|
443.64
|
432.60
|
257.41
|
239.06
|
277.51
|
221.89
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
1,631.20
|
1,512.29
|
1,074.36
|
1,010.42
|
1,055.95
|
889.14
|
|
|
|
|
|
|
Provision for Tax
|
475.37
|
529.49
|
374.26
|
353.74
|
368.67
|
305.54
|
|
|
|
|
|
|
Profit after Tax
|
1,155.83
|
982.80
|
700.10
|
656.68
|
687.28
|
583.60
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
4,161.76
|
4,094.71
|
3,485.12
|
3,122.67
|
2,798.71
|
2,113.04
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
196.18
|
2,825.87
|
2,864.98
|
2,693.46
|
2,330.65
|
1,943.47
|
|
|
|
|
|
|
Current Liabilities
|
1,784.63
|
2,350.70
|
1,742.59
|
1,595.62
|
1,456.66
|
1,686.04
|
|
|
|
|
|
|
Total Liabilities
|
6,142.57
|
9,385.18
|
8,208.14
|
7,539.55
|
6,699.15
|
5,846.89
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
560.43
|
3,467.15
|
3,530.69
|
3,272.62
|
2,828.41
|
2,437.14
|
|
|
|
|
|
|
Current Assets
|
5,332.81
|
5,804.14
|
4,562.00
|
4,139.13
|
3,757.61
|
3,305.42
|
|
|
|
|
|
|
Total Assets
|
6,142.57
|
9,385.18
|
8,208.14
|
7,539.55
|
6,699.15
|
5,846.89
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
--
|
8.36
|
12.75
|
--
|
|
|
|
|
|
|
Net Current Assets
|
3,548.18
|
3,453.43
|
2,819.41
|
2,543.51
|
2,300.95
|
1,619.37
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
145.61
|
140.34
|
135.06
|
129.79
|
605.36
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
671.07
|
723.04
|
602.97
|
573.46
|
611.47
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-335.06
|
-446.45
|
-602.40
|
-151.58
|
330.69
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-376.80
|
-363.40
|
-361.33
|
-285.59
|
-222.15
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-40.78
|
-86.81
|
-360.75
|
136.29
|
720.00
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
274.83
|
233.69
|
166.47
|
156.15
|
163.42
|
138.77
|
|
|
|
|
|
|
Cash EPS (₹)
|
--
|
248.08
|
181.78
|
171.41
|
177.08
|
153.53
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
--
|
973.65
|
828.70
|
742.51
|
665.48
|
502.44
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
105.00
|
75.00
|
70.00
|
70.00
|
55.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
159.57
|
171.93
|
143.38
|
136.36
|
145.40
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
240.33
|
231.43
|
184.66
|
176.81
|
156.55
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
39.92
|
32.54
|
34.10
|
42.98
|
45.33
|
|
|
|
|
|
|
ROE (%)
|
28.00
|
25.93
|
21.19
|
22.18
|
27.99
|
29.73
|
|
|
|
|
|
|
ROA (%)
|
19.71
|
11.32
|
9.03
|
9.38
|
11.15
|
11.04
|
|
|
|
|
|
|
EBIT Margin (%)
|
23.93
|
22.59
|
18.97
|
19.40
|
18.88
|
15.51
|
|
|
|
|
|
|
Net Margin (%)
|
21.29
|
18.85
|
15.31
|
15.52
|
15.57
|
12.88
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
21.82
|
17.47
|
16.29
|
16.32
|
14.25
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
6.60
|
10.78
|
8.15
|
-3.51
|
-3.98
|
-11.52
|
|
|
|
|
|
|
EBIT Growth (%)
|
17.81
|
31.93
|
5.79
|
-0.84
|
16.88
|
-17.55
|
|
|
|
|
|
|
Net Profit Growth (%)
|
27.18
|
40.38
|
6.61
|
-4.45
|
17.77
|
-13.51
|
|
|
|
|
|
|
EPS Growth (%)
|
27.18
|
40.38
|
6.61
|
-4.45
|
17.77
|
-13.51
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
17.49
|
11.61
|
11.58
|
32.45
|
16.56
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
39.13
|
30.86
|
36.61
|
33.04
|
36.93
|
45.40
|
|
|
|
|
|
|
Price / Book Value
|
10.19
|
7.41
|
7.36
|
6.95
|
9.07
|
12.54
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.98
|
1.46
|
1.23
|
1.36
|
1.16
|
0.87
|
|
|
|
|
|
|
EV/EBITDA
|
24.05
|
16.67
|
19.33
|
17.28
|
20.33
|
25.42
|
|
|
|
|
|
|
Close Price (₹)
|
8,308.90
|
7,246.80
|
6,100.10
|
5,156.05
|
6,036.75
|
6,300.00
|
|
|
|
|
|
|
High Price (₹)
|
9,387.70
|
7,948.00
|
6,940.25
|
6,600.00
|
6,800.00
|
6,414.95
|
|
|
|
|
|
|
Low Price (₹)
|
6,856.05
|
5,725.00
|
4,851.00
|
4,650.00
|
5,366.50
|
4,105.00
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
45,225.05
|
30,332.95
|
25,633.25
|
21,699.80
|
25,381.13
|
26,493.49
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
0.00
|
0.00
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
2.99
|
2.47
|
2.62
|
2.59
|
2.58
|
1.96
|
|
|
|
|
|
|
Quick Ratio
|
2.75
|
2.27
|
2.39
|
2.31
|
2.26
|
1.68
|
|
|
|
|
|
|
Interest Coverage
|
316.51
|
1,943.07
|
530.19
|
364.69
|
464.16
|
1,201.09
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Dec-12 | Dec-11 | Dec-10 | Dec-09 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
8.01
|
8.07
|
6.46
|
8.04
|
8.56
|
7.27
|
|
|
|
|
|
|
Asset Turnover
|
0.85
|
0.55
|
0.56
|
0.63
|
0.74
|
0.86
|
|
|
|
|
|
|
Receivable days
|
--
|
25.36
|
25.01
|
27.84
|
26.69
|
24.68
|
|
|
|
|
|
|
Inventory Days
|
--
|
33.39
|
36.30
|
38.05
|
37.10
|
35.19
|
|
|
|
|
|
|
Payable days
|
--
|
109.00
|
113.91
|
109.20
|
96.61
|
77.48
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-50.26
|
-52.61
|
-43.31
|
-32.82
|
-17.61
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
